Rectal Cancer Clinical Trial
— REPCAOfficial title:
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone
| NCT number | NCT04592289 |
| Other study ID # | COL-3 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 30, 2020 |
| Est. completion date | August 2024 |
The purpose of the study is to determine if short-term outcomes of rectal resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to rectal resections with only mechanical bowel preparation.
| Status | Recruiting |
| Enrollment | 622 |
| Est. completion date | August 2024 |
| Est. primary completion date | August 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - histologically confirmed adenocarcinoma of the rectum or rectosigmoid junction - clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) - indications for surgical rectal resection - ECOG status 0-2 - At least 18 years of age - Written informed consent Exclusion Criteria: - Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol - Pregnancy or breast feeding - Medical contraindications for surgical treatment - Any use of antibiotics 30 days prior to inclusion - Functioning stoma - Contraindications for use of MBP or OA drugs or their components - Indications for obstructive resection or abdominoperineal excision - Acute bowel obstruction, bleeding or perforation - Other malignancies not in remission |
| Country | Name | City | State |
|---|---|---|---|
| Russian Federation | GBUZ Moscow Clinical Scientific Center named after Loginov MHD | Moscow | |
| Russian Federation | I.M. Sechenov First Moscow State Medical University, Clinic of Oncology, Radiotherapy and Reconstructive Surgery | Moscow | |
| Russian Federation | Lomonosov Moscow State University Medical Research and Educational Center | Moscow | |
| Russian Federation | Ryazan State Clinical Hospital | Ryazan | |
| Russian Federation | Scientific-Research institute of Oncology named after N.N. Petrov | Saint Petersburg | |
| Russian Federation | Tomsk Regional Oncology Hospital | Tomsk | |
| Russian Federation | Volgograd State Medical University, Ministry of Health of Russia | Volgograd |
| Lead Sponsor | Collaborator |
|---|---|
| N.N. Petrov National Medical Research Center of Oncology |
Russian Federation,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Incisional surgical site infection (SSI) rate | Rate of incisional SSI in patients after rectal resections | 30 days | |
| Secondary | Anastomotic leak rate | Rate of clinical and/or radiological anastomotic leaks | 30 days | |
| Secondary | Intraabdominal and or pelvic abscess rate | 30 days | ||
| Secondary | Overall morbidity | Rate of patients with any complications after surgery | 30 days | |
| Secondary | Rate of intraoperative complications | Duration of surgical procedure | ||
| Secondary | Surgery duration in minutes | Duration of surgical procedure | ||
| Secondary | Quality of bowel preparation assessed by surgeon | Assessment of bowel preparation quality by surgeon (qualitative scale) | Day of surgery | |
| Secondary | Bowel preparation compliance | Rate of patients in experimental arm undergoing complete bowel preparation according to protocol | Day of surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
| Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
| Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
| Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
| Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
| Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
| Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
| Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
| Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
| Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
| Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
| Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A |